Discussion about this post

User's avatar
Dr. Axel Meierhoefer 🏕️🔥's avatar

I think it is possible that the benefits of the $70B will take a little longer. I have supported biotech projects for almost two decades and it is probably one of the longest life cycles from innovation to profits. Even acquisitions can only cut that by so much. Covid was unusual and there will be consequences for a long time due to the haste.

Expand full comment
Tim's avatar

Interesting chart on the 1 month Nasdaq 100 Ryan

Expand full comment
2 more comments...

No posts